Access to anti-retroviral drugs, male in Georgia
Georgia: Access to anti-retroviral drugs, male was 72.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Georgia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Georgia is 72.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 4.3% on the previous year and up 38.5% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Georgia peaked at 72.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Georgia 65th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Georgia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 7.0% | — |
| 2005 | 16.0% | +128.6% |
| 2006 | 23.0% | +43.8% |
| 2007 | 24.0% | +4.3% |
| 2008 | 27.0% | +12.5% |
| 2009 | 30.0% | +11.1% |
| 2010 | 30.0% | +0.0% |
| 2011 | 36.0% | +20.0% |
| 2012 | 46.0% | +27.8% |
| 2013 | 50.0% | +8.7% |
| 2014 | 52.0% | +4.0% |
| 2015 | 57.0% | +9.6% |
| 2016 | 62.0% | +8.8% |
| 2017 | 65.0% | +4.8% |
| 2018 | 66.0% | +1.5% |
| 2019 | 69.0% | +4.5% |
| 2020 | 69.0% | +0.0% |
| 2021 | 69.0% | +0.0% |
| 2022 | 68.0% | -1.4% |
| 2023 | 69.0% | +1.5% |
| 2024 | 72.0% | +4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 12.7% | 0.0% | 30.0% | 10 |
| 2010s | 53.3% | 30.0% | 69.0% | 10 |
| 2020s | 69.4% | 68.0% | 72.0% | 5 |
Countries ranked near Georgia
More gender data for Georgia
- Child population (UN estimates and projections) 701.95 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.78 % change on previous year (2030)
- Population 3,089 (2030)
- Working-age population (UN estimates and projections) 3,089 (2030)
- Population (UN estimates and projections), annual growth rate 0.507 % change on previous year (2030)
- Age population, age 00, female, interpolated 20,506 (2025)
- Age population, age 00, male, interpolated 21,826 (2025)
- Age population, age 01, female, interpolated 20,888 (2025)
- Age population, age 01, male, interpolated 22,233 (2025)
- Age population, age 02, female, interpolated 21,234 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Georgia?
- Access to anti-retroviral drugs, male in Georgia was 72.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Georgia?
- The highest recorded value was 72.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Georgia?
- The lowest recorded value was 0.0% in 2000.
- How does Georgia rank for access to anti-retroviral drugs, male?
- Georgia ranks 65th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Georgia?
- Over the last ten years it is up 38.5%. The long-run trend across the full record is volatile.
- Where does this Georgia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.